Answers are grounded in this paper and cite their sources.
Dr. Demitrack is Vice President and Chief Medical Officer, Neuronetics, Inc., One Great Valley Parkway, Suite 2, Malvern, PA 19355; E-mail: [email protected]. The author has disclosed that he is a stock shareholder of Neuronetics, Inc., Eli Lilly, and Wyeth Pharmaceuticals. The author also has disclosed that the use of the NeuroStar TMS Therapy System as well as the use of estrogen, ketoconazole, lorazepam, and lithium carbonate has not been approved by the U.S. Food and Drug Administration for the treatment of major depression.
No takes yet. Share an insight, caveat, or question.
Mark A. Demitrack (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: